Literature DB >> 26722285

Intraoperative photodynamic diagnosis of lymph node metastasis in esophageal cancer patients using 5-aminolevulinic acid.

Masaaki Motoori1, Masahiko Yano1, Koji Tanaka1, Kentaro Kishi1, Hidenori Takahashi1, Masahiro Inoue2, Takuro Saito1, Keijiro Sugimura1, Yoshiyuki Fujiwara1, Osamu Ishikawa1, Masato Sakon1.   

Abstract

Lymph node metastasis is the strongest prognostic factor in esophageal cancer patients who have undergone esophagectomy. The accurate diagnosis of lymph node metastasis is important, but the pre-operative diagnostic accuracy is poor. The intraoperative diagnosis based on histopathological examination of frozen tissue specimens is complicated and time-consuming. Therefore, the establishment of a simple and rapid intraoperative diagnostic method is essential. Exogenous application of 5-aminolevulinic acid (ALA) causes a selective accumulation of protoporphyrin IX, which is a fluorescent substrate, in cancer cells. The present study evaluated the feasibility of photodynamic diagnosis using ALA (ALA-PDD) for lymph node metastasis in esophageal cancer. A total of 292 lymph nodes were analyzed from 8 esophageal squamous cell cancer patients treated with esophagectomy. The patients were administered ALA orally prior to surgery. Excised lymph nodes were cut in half and examined by spectrometer. The diagnostic results of ALA-PDD were compared to those of the histopathological examination. Among the 292 lymph nodes, 19 nodes (6.5%) were histologically metastatic and 21 nodes (7.2%) were PDD-positive. The sensitivity and specificity of ALA-PDD were 84.2% (16/19) and 98.2% (268/273), respectively. The area of cancer nests of the PDD-negative lymph nodes was <2 mm2. Metastatic lymph nodes, including cancer nests >4 mm2, were correctly diagnosed by ALA-PDD. In conclusion, this study demonstrated that ALA-PDD of lymph node metastasis in patients with esophageal cancer is feasible. Further investigation would make this method a simple and rapid intraoperative diagnostic tool.

Entities:  

Keywords:  aminolevulinic acid; esophageal cancer; intraoperative diagnosis; lymph node metastasis; photodynamic diagnosis

Year:  2015        PMID: 26722285      PMCID: PMC4665204          DOI: 10.3892/ol.2015.3685

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  17 in total

1.  Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization.

Authors:  H Messmann; R Knüchel; W Bäumler; A Holstege; J Schölmerich
Journal:  Gastrointest Endosc       Date:  1999-01       Impact factor: 9.427

2.  Staging laparoscopy using ALA-mediated photodynamic diagnosis improves the detection of peritoneal metastases in advanced gastric cancer.

Authors:  Kentaro Kishi; Yoshiyuki Fujiwara; Masahiko Yano; Masahiro Inoue; Isao Miyashiro; Masaaki Motoori; Tatsushi Shingai; Kunihito Gotoh; Hidenori Takahashi; Shingo Noura; Terumasa Yamada; Masayuki Ohue; Hiroaki Ohigashi; Osamu Ishikawa
Journal:  J Surg Oncol       Date:  2012-03-02       Impact factor: 3.454

3.  Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer.

Authors:  T Nishimaki; O Tanaka; N Ando; H Ide; H Watanabe; M Shinoda; W Takiyama; H Yamana; K Ishida; K Isono; M Endo; T Ikeuchi; T Mitomi; H Koizumi; M Imamura; T Iizuka
Journal:  Ann Thorac Surg       Date:  1999-12       Impact factor: 4.330

4.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

5.  Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.

Authors:  Dmitry I Daniltchenko; Claus R Riedl; Markus D Sachs; Frank Koenig; Kurosch L Daha; Heinz Pflueger; Stefan A Loening; Dietmar Schnorr
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

Review 6.  Current concepts in gastrointestinal photodynamic therapy.

Authors:  J Webber; M Herman; D Kessel; D Fromm
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

7.  A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes.

Authors:  Hiroshi Miyata; Masahiko Yano; Yuichiro Doki; Takushi Yasuda; Setsuko Yoshioka; Yurika Sugita; Shuji Takiguchi; Yoshiyuki Fujiwara; Morito Monden
Journal:  J Surg Oncol       Date:  2006-05-01       Impact factor: 3.454

8.  Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI.

Authors:  Ling-Fei Wu; Bing-Zhou Wang; Jia-Lin Feng; Wei-Rong Cheng; Guo-Re Liu; Xiao-Hua Xu; Zhi-Chao Zheng
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Radical lymph node dissection for cancer of the thoracic esophagus.

Authors:  H Akiyama; M Tsurumaru; H Udagawa; Y Kajiyama
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

10.  Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.

Authors:  P Hinnen; F W de Rooij; M L van Velthuysen; A Edixhoven; R van Hillegersberg; H W Tilanus; J H Wilson; P D Siersema
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

View more
  2 in total

Review 1.  Clinical application of photodynamic medicine technology using light-emitting fluorescence imaging based on a specialized luminous source.

Authors:  Tsutomu Namikawa; Kazune Fujisawa; Eri Munekage; Jun Iwabu; Sunao Uemura; Shigehiro Tsujii; Hiromichi Maeda; Hiroyuki Kitagawa; Hideo Fukuhara; Keiji Inoue; Takayuki Sato; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Med Mol Morphol       Date:  2018-04-04       Impact factor: 2.309

2.  A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.

Authors:  Hirotada Nishie; Hiromi Kataoka; Shigenobu Yano; Jun-Ichi Kikuchi; Noriyuki Hayashi; Atsushi Narumi; Akihiro Nomoto; Eiji Kubota; Takashi Joh
Journal:  Oncotarget       Date:  2016-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.